A novel treatment of central serous chorioretinopathy with topical anti-inflammatory therapy.
BMJ Case Rep
; 20122012 Sep 03.
Article
en En
| MEDLINE
| ID: mdl-22949003
ABSTRACT
A 45-year-old Caucasian female with diagnosis of central serous chorioretinopathy (CSCR) did not improve on conventional observational approach. She was not willing to proceed with photocoagulation or photodynamic therapy. An unconventional approach of topical anti-inflammatory (ketorolac, dexamethasone and hydrocortisone) preparation was prescribed. The course of her CSCR responded well on this unconventional treatment, but relapsed on cessation or tapering of treatment. After 18 weeks of treatment with a gradual taper, her condition resolved. The present case highlights an alternative but unconventional treatment of CSCR with prolonged use of anti-inflammatories.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Dexametasona
/
Hidrocortisona
/
Ketorolaco
/
Coriorretinopatía Serosa Central
/
Antiinflamatorios
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Límite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
BMJ Case Rep
Año:
2012
Tipo del documento:
Article
País de afiliación:
Australia